Plasminogen activation has been proposed to play a critical role in ca
ncer invasion and metastasis. The effects of complete ablation of plas
minogen activation in cancer was studied by inoculation of a metastati
c Lewis lung carcinoma expressing high levels of plasminogen activator
into plasminogen-deficient (Plg(-/-)) mice and matched control mice.
Primary tumors developed in all mice with no difference in the rate of
appearance between Plg(-/-) and control mice. However, the primary tu
mors in Plg(-/-) mice were smaller and less hemorrhagic and displayed
reduced skin ulceration. In addition, dissemination of the tumor to re
gional lymph nodes was delayed in Plg(-/-) mice. Surprisingly, no quan
titative differences were observed in lung metastasis between Plg(-/-)
and control mice. In addition, Pig deficiency was compatible with met
astasis of the primary tumor to a variety of other organs. Nevertheles
s, Plg(-/-) mice displayed a moderately increased survival after prima
ry tumor resection. These findings suggest that plasmin-mediated prote
olysis contributes to the morbidity and mortality of Lewis lung carcin
oma in mice, but sufficient proteolytic activity is generated in Plg(-
/-) mice for efficient tumor development and metastasis. (C) 1997 by T
he American Society of Hematology.